_video-6-impact-of-pcsk9-inhibition-in-very-high-risk-patients-and-how-to-increase-cost-effectiveness.jpg "Video 6 - Impact of PCSK9 Inhibition in Very High-Risk Patients and How to Increase Cost Effectiveness from pcsk Video Screenshot Preview")
GalleryPlay Video:
(Note: The default playback of the video is HD VERSION. If your browser is buffering the video slowly, please play the REGULAR MP4 VERSION or Open The Video below for better experience. Thank you!)
⏲ Duration: 10 min 44 sec
✓ Published: 26-Aug-2021
✓ Published: 26-Aug-2021
Share with your friends:
Whatsapp | Viber | Telegram | Line | SMS
Email | Twitter | Reddit | Tumblr | Pinterest
Related Videos
_video-6-impact-of-pcsk9-inhibition-in-very-high-risk-patients-and-how-to-increase-cost-effectiveness-arabic.webp "Video 6 - Impact of PCSK9 Inhibition in Very High-Risk Patients and How to Increase Cost Effectiveness(Arabic) from pcsk")
⏲ 10 min 81 sec ✓ 13-Sep-2021
_video-8-use-of-pcsk9-inhibitors-in-familial-hypercholesterolemia-patient.webp "Video 8 - Use of PCSK9 Inhibitors in Familial Hypercholesterolemia Patient from pcsk")
⏲ 10 min 80 sec ✓ 13-Sep-2021
_video-8-use-of-pcsk9-inhibitors-in-familial-hypercholesterolemia-patients-portuguese.webp "Video 8 - Use of PCSK9 Inhibitors in Familial Hypercholesterolemia Patients Portuguese from pcsk")
⏲ 10 min 80 sec ✓ 21-Sep-2021
_video-7-efficacy-feasibility-and-safety-of-early-use-of-monoclonal-pcsk9-inhib-after-an-acute-coronary-syndrome-portug.webp "Video 7 -Efficacy, Feasibility and Safety of Early Use of Monoclonal PCSK9 Inhib After an Acute Coronary Syndrome (Portuguese) from pcsk")
⏲ 11 min 60 sec ✓ 07-Sep-2021
_video-5-impact-of-blocking-circulating-pcsk9-with-monoclonal-antibodies-on-atherogenic-lipoproteins-arabic.webp "Video 5 -Impact of Blocking Circulating PCSK9 with Monoclonal Antibodies on Atherogenic Lipoproteins (Arabic) from pcsk")
⏲ 9 min 59 sec ✓ 30-Aug-2021
_video-5-impact-of-blocking-circulating-pcsk9-with-monoclonal-antibodies-on-atherogenic-lipoproteins.webp "Video 5 - Impact of Blocking Circulating PCSK9 with Monoclonal Antibodies on Atherogenic Lipoproteins from pcsk")
⏲ 9 min 59 sec ✓ 30-Aug-2021
_video-6-impact-of-pcsk9-inhibition-in-very-high-risk-patients-and-how-to-increase-cost-effectiveness-arabic.jpg)
_video-8-use-of-pcsk9-inhibitors-in-familial-hypercholesterolemia-patient.jpg)
_video-8-use-of-pcsk9-inhibitors-in-familial-hypercholesterolemia-patients-portuguese.jpg)
_video-7-efficacy-feasibility-and-safety-of-early-use-of-monoclonal-pcsk9-inhib-after-an-acute-coronary-syndrome-portug.jpg)
_video-5-impact-of-blocking-circulating-pcsk9-with-monoclonal-antibodies-on-atherogenic-lipoproteins-arabic.jpg)
_video-5-impact-of-blocking-circulating-pcsk9-with-monoclonal-antibodies-on-atherogenic-lipoproteins.jpg)
![[+]](/images/menu.gif){kind=small}